Autoantibody Dataset for Predicting PD-1 Inhibitor Response and Toxicity

Marco Iafolla's autoantibody data set was used in a project to predict patient response and toxicity to PD-1 inhibition. The data was identified from immuno-mass spectrometry analysis of serum samples. The dataset's specific size, temporal coverage, and geographic origin are not detailed in the available metadata.

Use Cases

• Predicting patient response to PD-1 inhibitor therapy based on serum autoantibody profiles.
• Modeling the risk of toxicity from PD-1 inhibition using autoantibody signatures.
• Identifying potential serum biomarkers for immunotherapy outcomes via immuno-mass spectrometry data.

Strengths

• Dataset is associated with a specific, peer-reviewed research project on PD-1 inhibition.
• Data originates from immuno-mass spectrometry, a technique for protein profiling.

Limitations

• Row count and dataset scale are unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Marco Iafolla via paperswithcode

Collection Method

Identified from immuno-mass spectrometry analysis of serum samples.